tiprankstipranks
Trending News
More News >
Utah Medical Products (UTMD)
NASDAQ:UTMD
US Market

Utah Medical Products (UTMD) Financial Statements

Compare
121 Followers

Utah Medical Products Financial Overview

Utah Medical Products's market cap is currently $214.93M. The company's EPS TTM is $0.802; its P/E ratio is 19.12; and it has a dividend yield of 2.15%. Utah Medical Products is scheduled to report earnings on January 29, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 38.52M$ 40.90M$ 50.22M$ 52.28M$ 49.05M
Gross Profit$ 19.88M$ 24.14M$ 30.04M$ 32.20M$ 30.92M
Operating Income$ 11.40M$ 13.59M$ 16.78M$ 19.79M$ 18.88M
EBITDA$ 17.06M$ 16.44M$ 24.75M$ 26.87M$ 26.16M
Net Income$ 11.29M$ 13.87M$ 16.64M$ 16.47M$ 14.79M
Balance Sheet
Cash & Short-Term Investments$ 85.76M$ 82.98M$ 92.87M$ 75.05M$ 60.97M
Total Assets$ 122.54M$ 122.54M$ 135.46M$ 123.87M$ 115.64M
Total Debt$ 0.00$ 338.00K$ 295.00K$ 341.00K$ 396.00K
Net Debt$ -85.76M$ -82.69M$ -92.57M$ -74.71M$ -60.58M
Total Liabilities$ 3.27M$ 5.11M$ 7.14M$ 9.62M$ 8.50M
Stockholders' Equity$ 119.27M$ 117.43M$ 128.31M$ 114.25M$ 107.14M
Cash Flow
Free Cash Flow$ 0.00$ 14.60M$ 21.64M$ 20.33M$ 20.65M
Operating Cash Flow$ 0.00$ 14.83M$ 22.28M$ 21.15M$ 21.20M
Investing Cash Flow$ 0.00$ -208.00K$ -639.00K$ -818.00K$ -552.00K
Financing Cash Flow$ 0.00$ -23.84M$ -4.17M$ -5.48M$ -10.90M
Currency in USD

Utah Medical Products Earnings and Revenue History

Utah Medical Products Debt to Assets

Utah Medical Products Cash Flow

Utah Medical Products Forecast EPS vs Actual EPS